NASDAQ: APVO

Should investors be concerned about APVO’s high price-to-sales ratio?
Arcelia Reed
Aptevo Therapeutics Inc (APVO)’s stock is trading at $1.41 at the moment marking a fall of -6.00% from the last ...
Aptevo Therapeutics Inc (APVO)’s stock is trading at $1.41 at the moment marking a fall of -6.00% from the last ...